Join
Live feed
·
INSIDERFilingvia Quantisnow
TScan Therapeutics Inc. logo

Large owner Lynx1 Capital Management Lp bought $4,114 worth of shares (947 units at $4.34) (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
TCRX· TScan Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TCRX (TScan Therapeutics Inc.) and more on Quantisnow.